Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 in active rheumatoid arthritis
NCT00076206Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Dec 2003
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of temsirolimus in rheumatoid arthritis (RA), sponsored by Pfizer. Started Dec 2003; status: terminated.
02
Drugs
temsirolimus
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00076206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00076206.